These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 22973674)
1. Evaluation of serotype-specific immunity to Streptococcus pneumoniae in pregnant women and cord blood of infants: impact of race and ethnicity. Choudhury SA; Ladson G; Kabir MS J Natl Med Assoc; 2012; 104(5-6):251-7. PubMed ID: 22973674 [TBL] [Abstract][Full Text] [Related]
11. Herd immunity and pneumococcal conjugate vaccine: a quantitative model. Haber M; Barskey A; Baughman W; Barker L; Whitney CG; Shaw KM; Orenstein W; Stephens DS Vaccine; 2007 Jul; 25(29):5390-8. PubMed ID: 17583392 [TBL] [Abstract][Full Text] [Related]
12. Changes in Streptococcus pneumoniae serotype distribution in invasive disease and nasopharyngeal carriage after the heptavalent pneumococcal conjugate vaccine introduction in Bogotá, Colombia. Parra EL; De La Hoz F; Díaz PL; Sanabria O; Realpe ME; Moreno J Vaccine; 2013 Aug; 31(37):4033-8. PubMed ID: 23680440 [TBL] [Abstract][Full Text] [Related]
13. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway. Steens A; Bergsaker MA; Aaberge IS; Rønning K; Vestrheim DF Vaccine; 2013 Dec; 31(52):6232-8. PubMed ID: 24176490 [TBL] [Abstract][Full Text] [Related]
14. Hyporesponsiveness to the infecting serotype after vaccination of children with seven-valent pneumococcal conjugate vaccine following invasive pneumococcal disease. Tamura K; Matsubara K; Ishiwada N; Nishi J; Ohnishi H; Suga S; Ihara T; Chang B; Akeda Y; Oishi K; Vaccine; 2014 Mar; 32(13):1444-50. PubMed ID: 24486367 [TBL] [Abstract][Full Text] [Related]
16. Age-stratified prevalences of pneumococcal-serotype-specific immunoglobulin G in England and their relationship to the serotype-specific incidence of invasive pneumococcal disease prior to the introduction of the pneumococcal 7-valent conjugate vaccine. Balmer P; Borrow R; Findlow J; Warrington R; Frankland S; Waight P; George R; Andrews N; Miller E Clin Vaccine Immunol; 2007 Nov; 14(11):1442-50. PubMed ID: 17881503 [TBL] [Abstract][Full Text] [Related]
17. The effect of an alternative reduced-dose infant schedule and a second year catch-up schedule with 7-valent pneumococcal conjugate vaccine on pneumococcal carriage: a randomized controlled trial. Dagan R; Givon-Lavi N; Porat N; Greenberg D Vaccine; 2012 Jul; 30(34):5132-40. PubMed ID: 22683519 [TBL] [Abstract][Full Text] [Related]
18. Antibiotic resistance and serotype distribution of invasive pneumococcal diseases before and after introduction of pneumococcal conjugate vaccine in the Kingdom of Saudi Arabia (KSA). Shibl AM; Memish ZA; Al-Kattan KM Vaccine; 2012 Dec; 30 Suppl 6():G32-6. PubMed ID: 23228355 [TBL] [Abstract][Full Text] [Related]
19. Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait. Mokaddas E; Albert MJ Vaccine; 2012 Dec; 30 Suppl 6():G37-40. PubMed ID: 23228356 [TBL] [Abstract][Full Text] [Related]
20. Effects of Infant Pneumococcal Conjugate Vaccination on Serotype Distribution in Invasive Pneumococcal Disease among Children and Adults in Germany. van der Linden M; Falkenhorst G; Perniciaro S; Imöhl M PLoS One; 2015; 10(7):e0131494. PubMed ID: 26132078 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]